Table 2 HPV infection among 133 cases of cervical cancer and 281 controls
From: HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study
Cases | Controls | ORa (95% CI) | |||
|---|---|---|---|---|---|
No. | (%) | No. | (%) | ||
HPV | |||||
Negative | 10 | 7.5 | 242 | 86.1 | 1 |
Positive (any type) | 123 | 92.5 | 39 | 13.9 | 39.3 (16.0–96.5) |
Multiple infection | |||||
No | 118 | 95.9 | 33 | 84.6 | 1 |
Yes | 5 | 4.1 | 6 | 15.4 | 0.2 (0.02–1.7) |
HPV type | |||||
Negative | 10 | 7.5 | 242 | 86.1 | Reference |
16 | 108 | 81.2 | 14 | 5.0 | 49.3 (19.2–126.3) |
18 | 7 | 5.3 | 1 | 0.4 | 31.7 (2.5–407.0) |
HPV 1, 6, 11 | 0 | 0.0 | 4 | 1.5 | <0.001 (<0.001–999) |
30s (31, 33, 35) | 3 | 2.4 | 14 | 5.0 | 1.6 (0.4–6.9) |
Multiple infection | 5 | 3.8 | 6 | 2.2 | 13.8 (2.6–73.8) |